Health ministry says no third dose booster planned, focus is on second jab

Clearing the air on whether a booster vaccine dose will be given after two doses, the country’s apex health research institute said that a there were no such plans. Moreover, the Ministry has now urged states where many healthcare workers have not yet got their second dose vaccine to speed up the process by using line-lists generated by the Co-WIN platform.

Speaking to the media, Balram Bhargava, director general of the Indian Council of Medical Research (ICMR) said that studies in India have also found that more than 95 per cent of the antibodies (generated due to vaccination) persist for over a year.

Bhargava said: “Currently, the talk of booster is not pertinent. The call of the hour is to give the two-dose vaccination, or which is the full vaccination. That is our agenda and that has to be continued.”

He further added that “We have had some studies in India, including Bangalore, where some hospitals have found that more than 95 per cent of the antibodies persist for over a year. Therefore, the talk of booster dose is not pertinent.”

Meanwhile, around 85 per cent of healthcare workers have got their second Covid-19 vaccine dose, even though the healthcare worker vaccination was prioritised by India. Around 99 per cent of them have got their first dose compared to 100 per cent frontline workers who have received their first shot.

Health secretary Rajesh Bhushan said that they have indeed taken up the matter with concerned states where second dose vaccination rates among healthcare workers has been low. “There is a facility in the CoWin system where line-listing of people who have missed their second dose can be done. So, states have got those lists, and they are looking into it that these people can be given the second dose,” he added.

There have been reports of irregularities with regards to vaccinations–like dead people getting vaccines, or delayed data entry. The Health Ministry cleared the air on the matter.

“The allegation of delayed data entry was made with respect to Bihar.

We got it checked and found it to be absolutely baseless. Bihar, on an average, inoculates 3-5 lakh people a day. To expect that one will inoculate 3-5 lakh people a day and not give them digital certificates, they will not get messages, not upload that data, would be something totally unrealistic. We have asked the concerned media houses who had done the story if they could share specific details of villages and people, and then we can check those claims,” Bhushan explained.

As far as dead people being given vaccines is concerned, that was an instance reported in Madhya Pradesh. “We found that the registration was done when the person was alive, and on the date the person would have got the vaccine, unfortunately he died. There was an inadvertent error by the vaccinator in pressing the button against his name. It has been subsequently corrected,” he clarified.

India working actively on a new dengue vaccine

Balram Bhargava , director general of the Indian Council of Medical Research (ICMR) said that developing a dengue vaccine is an important agenda. “Several dengue strains have been licensed to various companies in India. We are working very closely with them to do the trials. Many of these companies have done trials outside the country, and now we are planning to do more rigorous trials with these dengue vaccines,” he added.

Meanwhile, on the matter Emergency Use license (EUL) for indigenous vaccine Covaxin developed jointly by the ICMR and Bharat Biotech, Bhargava said “We know that scientific data, public health considerations and international health requirements are all considered on which an EUL is given by the World Health Organisation (WHO). All these have been provided, and based on these the WHO will decide accordingly.”

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor